Horizon 2020, the EU’s largest research and innovation program, has awarded an SME phase 1 grant to NextFerm.  This grant will enable NextFerm to continue its development for its groundbreaking AstafermTM a yeast-derived, fermented astaxanthin technology for human nutrition.